Heska (HSKA) Scheduled to Post Earnings on Tuesday

Heska (NASDAQ:HSKA) is scheduled to be announcing its earnings results before the market opens on Tuesday, February 26th. Analysts expect the company to announce earnings of $0.75 per share for the quarter.

NASDAQ HSKA opened at $98.56 on Monday. The stock has a market cap of $747.99 million, a price-to-earnings ratio of 47.61 and a beta of 0.91. Heska has a fifty-two week low of $57.15 and a fifty-two week high of $114.50.

Get Heska alerts:

In other Heska news, Director G Irwin Gordon sold 4,000 shares of the stock in a transaction dated Thursday, November 29th. The shares were sold at an average price of $102.00, for a total value of $408,000.00. Following the transaction, the director now directly owns 25,074 shares of the company’s stock, valued at approximately $2,557,548. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO Kevin S. Wilson sold 1,631 shares of the stock in a transaction dated Friday, November 30th. The shares were sold at an average price of $104.00, for a total transaction of $169,624.00. The disclosure for this sale can be found here. Insiders sold a total of 36,141 shares of company stock valued at $3,547,787 over the last quarter. 15.90% of the stock is currently owned by company insiders.

Several equities analysts recently issued reports on HSKA shares. Zacks Investment Research upgraded Heska from a “hold” rating to a “buy” rating and set a $101.00 price target on the stock in a research note on Thursday, January 10th. Canaccord Genuity reissued a “buy” rating and issued a $118.00 target price on shares of Heska in a report on Wednesday, February 20th. Finally, BidaskClub downgraded Heska from a “buy” rating to a “hold” rating in a report on Thursday, November 8th. Four analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus target price of $110.50.

TRADEMARK VIOLATION NOTICE: “Heska (HSKA) Scheduled to Post Earnings on Tuesday” was originally reported by Ticker Report and is the sole property of of Ticker Report. If you are reading this article on another site, it was illegally copied and republished in violation of US and international copyright and trademark law. The correct version of this article can be viewed at https://www.tickerreport.com/banking-finance/4177338/heska-hska-scheduled-to-post-earnings-on-tuesday.html.

About Heska

Heska Corporation manufactures, sells, and markets veterinary diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Europe, and internationally. The company's Core Companion Animal Health segment offers Element DC and DRI-CHEM 7000 veterinary chemistry analyzers for blood chemistry and electrolyte analysis; HT5 and HEMATRUE veterinary hematology analyzers to measure blood cell and platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; COAG veterinary analyzers; Element i immunodiagnostic analyzers; and IV infusion pumps.

Featured Article: What is the quiet period?